Prof. Dr. med. Arndt Hartmann

Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie

Langerhans Cell Histiocytosis Occurring in a Renal Cell Carcinoma is a Neoplastic Process: Clinicopathologic and Molecular Study of Five Cases (2020) Agaimy A, Bonert M, Naqvi A, Wang C, Hes O, Trpkov K, Gibson I, Hartmann A Conference contribution Renal Cell Carcinoma with "Gonadal Sex-cord Stromal tumor-like" Features: Analysis of 5 Cases of Novel Renal Entity (2020) Wang G, Amin M, Grossmann P, Hayes M, Hartmann A, Agaimy A, Lopez J, Hes O Conference contribution Polypoid Undifferentiated Rhabdoid Carcinoma in the Intestine: A Distinctive Presentation of Metastatic -Mostly Occult -Undifferentiated Non-small Cell Lung Carcinoma Illustrated in a Series of 12 Cases (2020) Agaimy A, Daum O, Michal M, Hartmann A, Lauwers G Conference contribution Comparison of Intrinsic PAM50 Gene Expression Analysis and Immunohistochemical Subtypes of Salivary Duct Carcinoma (2020) Erber R, Stoehr R, Haller F, Haderlein M, Hartmann A, Agaimy A Conference contribution Discrimination analysis of breast calcifications using x-ray dark-field radiography (2020) Rauch T, Rieger J, Pelzer G, Horn F, Erber R, Wunderle M, Emons J, et al. Journal article Predictive value of fibroblast growth factor receptor (FGFR) alterations on anti-PD-(L)1 treatment outcomes in patients (Pts) with advanced urothelial cancer (UC): Pooled analysis of real-world data (2020) Kim WY, Rose T, Roghmann F, Eckstein M, Jarczyk J, Zengerling F, Sikic D, et al. Conference contribution Association of KRT20 and KRT5 with response to neoadjuvant chemotherapy in patients diagnosed with muscle invasive bladder cancer (2020) Roghmann F, Reike M, Wirtz R, Kriegmair M, Erben P, Tully K, Weyerer V, et al. Conference contribution Smoking status and PD-L1 mRNA-expression as a predictor of response to neoadjuvant chemotherapy in patients diagnosed with muscle invasive bladder cancer (2020) Reike M, Juette H, Wirtz R, Erben P, Tully K, Eckstein M, Weyerer V, et al. Conference contribution Variant morphology and random chromosomal integration of BK polyomavirus in posttransplant urothelial carcinomas (2020) Bertz S, Enßer A, Stöhr R, Eckstein M, Apel H, Mayr D, Büttner-Herold M, et al. Journal article A Randomized Phase II Study of Nivolumab Plus Ipilimumab Versus Standard of Care in Previously Untreated and Advanced Non-Clear Cell Renal Cell Carcinoma (Suniforecast) (2020) Ahrens M, Escudier B, Boleti E, Grimm MO, Goupir MG, Barthelemy P, Gravis G, et al. Conference contribution